228 related articles for article (PubMed ID: 24210327)
1. Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection.
Bae CB; Kim SS; Ahn SJ; Cho HJ; Kim SR; Park SY; Song GW; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Shin SJ; Cho SW; Cheong JY
J Clin Virol; 2013 Dec; 58(4):641-6. PubMed ID: 24210327
[TBL] [Abstract][Full Text] [Related]
2. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
[TBL] [Abstract][Full Text] [Related]
3. Relationship between liver injury and serum cytokeratin 18 levels in asymptomatic hepatitis B virus carriers and in patients with chronic hepatitis B infection.
Balkan A; Yılmaz N; Balkan Y; Koruk I; Örkmez M; Aydınlı M; Koruk M
Arab J Gastroenterol; 2017 Jun; 18(2):98-103. PubMed ID: 28579343
[TBL] [Abstract][Full Text] [Related]
4. The expression of serum M30 and M65 in chronic hepatitis B patients with non-alcoholic fatty liver disease.
Liang J; Han T; Gao YT; Jing L; Ma Z
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4123-9. PubMed ID: 26592838
[TBL] [Abstract][Full Text] [Related]
5. Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.
Cheong JY; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Cho SW
Liver Int; 2011 Oct; 31(9):1352-8. PubMed ID: 21745311
[TBL] [Abstract][Full Text] [Related]
6. Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease.
Świderska M; Jaroszewicz J; Parfieniuk-Kowerda A; Rogalska-Płońska M; Stawicka A; Panasiuk A; Flisiak R
Mediators Inflamm; 2017; 2017():3480234. PubMed ID: 28827897
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure.
Zheng SJ; Liu S; Liu M; McCrae MA; Li JF; Han YP; Xu CH; Ren F; Chen Y; Duan ZP
World J Gastroenterol; 2014 Mar; 20(9):2403-11. PubMed ID: 24605039
[TBL] [Abstract][Full Text] [Related]
8. Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B.
Eren F; Yilmaz Y; Kose S; Ozdemir FT; Yonal O; Kurt R; Ozdogan O; Avsar E
Clin Chim Acta; 2010 Dec; 411(23-24):2029-32. PubMed ID: 20807521
[TBL] [Abstract][Full Text] [Related]
9. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
[TBL] [Abstract][Full Text] [Related]
10. Changes of serum levels of keratin-18 fragments in hepatitis B e antigen-negative chronic hepatitis B patients under oral antiviral therapy.
Giannousis IP; Manolakopoulos SG; Hadziyannis E; Georgiou A; Papatheodoridis GV
Antivir Ther; 2011; 16(4):505-14. PubMed ID: 21685538
[TBL] [Abstract][Full Text] [Related]
11. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
Papatheodoridis GV; Manesis EK; Manolakopoulos S; Elefsiniotis IS; Goulis J; Giannousis J; Bilalis A; Kafiri G; Tzourmakliotis D; Archimandritis AJ
Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246
[TBL] [Abstract][Full Text] [Related]
12. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Han Y; Tang Q; Zhu W; Zhang X; You L
J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.
Brunetto MR; Oliveri F; Colombatto P; Moriconi F; Ciccorossi P; Coco B; Romagnoli V; Cherubini B; Moscato G; Maina AM; Cavallone D; Bonino F
Gastroenterology; 2010 Aug; 139(2):483-90. PubMed ID: 20451520
[TBL] [Abstract][Full Text] [Related]
14. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of hepatocyte expression of hepatitis B viral core antigen and the clinicopathological characters in chronic hepatitis B patients].
Ding Y; Zou Z; Xu X; Zhao Z; Jia W; Fang Y; Li Y; Guo Y; Wang G
Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):185-9. PubMed ID: 24824119
[TBL] [Abstract][Full Text] [Related]
18. [Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT].
Liu SQ; Zhu XJ; Sun XH; Li M; Gao YQ
Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):348-52. PubMed ID: 22971279
[TBL] [Abstract][Full Text] [Related]
19. e-antigen-negative chronic hepatitis B in Bangladesh.
Ahmad N; Alam S; Mustafa G; Adnan AB; Baig RH; Khan M
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):379-82. PubMed ID: 18693173
[TBL] [Abstract][Full Text] [Related]
20. Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.
Li MR; Lu JH; Ye LH; Sun XL; Zheng YH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH
Medicine (Baltimore); 2016 Aug; 95(34):e4422. PubMed ID: 27559949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
